Mudanças entre as edições de "Página principal"

De Mundo Sirrus
Ir para: navegação, pesquisa
m
m (Limpou toda a página)
Linha 1: Linha 1:
Independent one-way ANOVAs showed that flupenthixol decreased the amount of occasions STs engaged the lever (impact of remedy, F(three,28) = 43.470, p  0.001; Figure 4B), and did so at all doses tested (ps  0.001). In contrast, flupenthixol had no substantial impact on the number of head entries in to the meals cup in GTs (no effect of remedy, F(3,28) = 1.716, p = 0.183; Figure 4B). Latency--Finally, flupenthixol administration influenced the rapidity of strategy, measured as the latency from CS onset towards the initially lever deflection or head entry (impact of remedy, F(three,30.012) = 21.966, p  0.001; Figure 4C), but once again, this impact varied as a function of group (group X treatment interaction, F(three,28) = 9.751, p  0.001). Independent one-way ANOVAs showed that flupenthixol enhanced the latency of approach to the CS in STs (effect of therapy, F(three,28) = 28.122, p  0.001; Figure 4C), and did so at all doses tested (ps  0.001). Having said that, although the effect of flupenthixol on latency in GTs was statistically considerable depending on the one-way ANOVA (effect of treatment, F(three,28) = three.048, pNIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptEur J Neurosci. Author manuscript; accessible in PMC 2013 August 01.Saunders and RobinsonPage= 0.044; Figure 4C), none in the paired comparisons revealed a statistically significant impact of any provided dose.NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptFigure 4D shows the amount of meals cup head entries rats created in the course of the inter-trial interval (ITI), the period amongst CS presentations, which serves as an indirect measure with the effect of flupenthixol on common motor activity. GTs produced extra non-CS meals cup entries than STs (impact of group, F(three,28) = 5.698, p = 0.024). Even so, by the end of training their price of meals cup entries during the CS period (imply = 0.376 entriess, SEM = 0.055) was substantially larger than during non-CS periods (imply = 0.072 entriess, SEM = 0.010) (see also Meyer et al., 2012), [http://usspire.com/members/degree42market/activity/770442/ http://usspire.com/members/degree42market/activity/770442/] indicating that GTs discriminated involving CS and non-CS periods. Importantly, there was no impact of flupenthixol administration around the number of inter-trial interval food cup entries produced by either group (no effect of therapy, F(3,28) = 0.132, p = 0.94), indicating that flupenthixol did not impair basic motor activity at the doses we applied. Impact of flupenthixol around the topography of the CR in STs, GTs and INs Figure 5A shows a extra detailed analysis of the effects of just the highest dose of flupenthixol (20 g) on various kinds of CRs in STs, GTs and INs (as defined above and shown in Figure 1). For the sake of simplicity, CUP Initial and CUP ONLY trials had been grouped collectively (CUP trials) and LEVER Initially and LEVER ONLY trials were grouped together (LEVER trials). Figure 5A shows that in all groups flupenthixol decreased the proportion of LEVER trials, but not CUP trials, and enhanced NONE trials. Goal-trackers: As anticipated, following car GTs made mostly CUP trials (78  CUP, 16  LEVER, and six  NONE trials). Following 20 g flupenthixol, CUP trials have been modestly decreased to 70  of trials, while LEVER trials were halved to 8  and NONE trials increased to 22  (Figure 5A, left pie graphs).
+
 

Edição das 17h06min de 9 de janeiro de 2019